Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had revenue of $364.25M in the quarter ending June 30, 2026, with 71.17% growth. This brings the company's revenue in the last twelve months to $1.28B, up 149.04% year-over-year. In the year 2025, Madrigal Pharmaceuticals had annual revenue of $958.40M with 432.05% growth. That makes Madrigal Pharmaceuticals the 6,565th largest company in the world by revenue and 1,623rd in the United States.

• Revenue (ttm): $1.28B
• Revenue Growth: +149.04%
• P/S Ratio: 8.27
• Revenue / Employee: $1,403,213
• Employees: 915
• Market Cap: 10.62B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	958.40M	778.27M	432.05%
Dec 31, 2024	180.13M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	147.00K	-7.44M	-98.06%
Dec 31, 2011	7.58M	-7.22M	-48.77%
Dec 31, 2010	14.80M	-129.44M	-89.74%
Dec 31, 2009	144.25M	141.63M	5,416.06%
Dec 31, 2008	2.62M	1.87M	251.95%
Dec 31, 2007	743.00K	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-

Data Source: Fiscal.ai Last updated: Jul 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error